The independent source for health policy research, polling, and news.
If your doctor recommends a big test or procedure, this tool can help you talk through options collaboratively. It works at a routine checkup or in high-stakes medical situations like childbirth.
Poisons from Jacksonville, Florida’s “Brown’s Dump” seeped into the lifeblood of residents. The harm to their physical and mental health is tied today to another public health crisis: high rates of gun violence among children.
Rising healthcare costs are upending the lives of Americans. People are forgoing health insurance, rationing medications, cutting back on doctor visits, and putting off health procedures they can’t afford. But bringing the costs down won’t be easy.
A proposed federal rule could dramatically reduce access to remote patient monitoring programs for people on Medicare. The services aim to keep patients out of the hospital by giving them devices to monitor their health at home, but critics say there isn’t enough oversight.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
In a race that could help decide control of Congress, Republican U.S. Rep. David Valadao is trying to hold on to his swing-district seat. The congressman didn’t mention healthcare at a recent campaign rally in Bakersfield, but voters can’t stop talking about it.
Hundreds of thousands of lawfully present immigrants could lose government health coverage. This change stems from healthcare cuts in a GOP budget law. KFF Health News’ Andrew Jones tells WAMU’s “Health Hub” which Medicaid enrollees are affected and shares resources for newly uninsured people in the Washington, D.C., area.
As open enrollment for Affordable Care Act health insurance kicks off, consumers face rising premiums, additional identity checks, and fewer brokers.
Healthcare makes up a growing share of the U.S. economy — and household budgets. We break down how much money the nation is spending and on what.
Republicans tried to backload Medicaid cuts in 2025’s One Big Beautiful Bill Act so they would take effect after this year’s elections, but that’s not stopping Democrats from using them to hammer their opponents. Meanwhile, the Trump administration ramps up its war on fraud. Alice Miranda Ollstein of Politico, Amanda Seitz of KFF Health News, and Liz Essley Whyte of The Wall Street Journal join KFF Health News’ Julie Rovner to discuss these stories and more. Also, Rovner speaks with Ollstein about her new book, “Side Effects.”
Employers saw their healthcare premiums rise 5% this year — and some passed on that burden to workers — as the cost of family coverage in job-based insurance exceeds $28,000 for family plans.
The “KFF Health News Minute” brings original healthcare and health policy reporting from our newsroom to the airwaves each week.
The Trump administration has tied billions in rural health funding for states partly to the policy commitments they make, including ending their certificate of need, or CON, laws governing the construction of new hospitals.
The Trump administration pushed back a rule — until after the midterm elections — that would complicate Americans’ access to less expensive medication imports from Canada and other countries.
Most of Georgia’s counties are without a labor and delivery unit. To fill the gap, the state is looking to equip emergency rooms to handle obstetric emergencies. Advocates and doctors worry, however, that the ER is being used as a stopgap.
Oregon passed a law to require hospitals to proactively screen patients to see if they qualify for financial aid. Patients got immediate relief. Hospitals pushed to roll back the law following federal cuts to Medicaid and Affordable Care Act subsidies.
A year after launching an inquiry into companies, including Deloitte, that receive billions in taxpayer dollars to build complex computer systems determining Medicaid eligibility, senators are urging the federal government to impose stricter rules.
As people take a greater number of medications across years or decades, experts say the risk for adverse drug interactions increases. One way to advocate for yourself? Keep a list of your meds handy.
The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
Experimental peptides are all the rage on longevity and “optimization” podcasts, but a lot of the chatter is misleading.
Noticias en español